The global cancer immunotherapy market was valued at USD 123.45 billion in 2022 and is estimated to reach approximately USD 236.13 billion by 2031, at a CAGR of 9.76% from 2023 to 2031.
Cancer immunotherapy is a cancer treatment, which improves the immune system's ability to fight cancer. This therapy is desirable than the old technique due to it provides long-term cancer protection, has less side effects, and treats a broader range of cancer. Cancer immunotherapy is used in several types of cancers includes melanoma, prostate cancer, breast cancer, colorectal cancer, lung...
0 Yorumlar
0 hisse senetleri